CN113730825A - Optical medical device - Google Patents
Optical medical device Download PDFInfo
- Publication number
- CN113730825A CN113730825A CN202111049756.1A CN202111049756A CN113730825A CN 113730825 A CN113730825 A CN 113730825A CN 202111049756 A CN202111049756 A CN 202111049756A CN 113730825 A CN113730825 A CN 113730825A
- Authority
- CN
- China
- Prior art keywords
- substrate
- layer
- electro
- photomedical
- deformation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 230000003287 optical effect Effects 0.000 title description 4
- 239000000758 substrate Substances 0.000 claims abstract description 114
- 238000002955 isolation Methods 0.000 claims abstract description 26
- 239000000463 material Substances 0.000 claims description 48
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 9
- 230000005684 electric field Effects 0.000 claims description 9
- 239000002041 carbon nanotube Substances 0.000 claims description 6
- 229910021393 carbon nanotube Inorganic materials 0.000 claims description 6
- 239000004020 conductor Substances 0.000 claims description 6
- 239000011324 bead Substances 0.000 claims description 4
- 239000011248 coating agent Substances 0.000 claims description 4
- 238000000576 coating method Methods 0.000 claims description 4
- 239000003086 colorant Substances 0.000 claims description 4
- 229920000642 polymer Polymers 0.000 claims description 4
- 229910052782 aluminium Inorganic materials 0.000 claims description 3
- 229910052802 copper Inorganic materials 0.000 claims description 3
- 229910052737 gold Inorganic materials 0.000 claims description 3
- 229910021389 graphene Inorganic materials 0.000 claims description 3
- 229910001338 liquidmetal Inorganic materials 0.000 claims description 3
- 229910052709 silver Inorganic materials 0.000 claims description 3
- 238000001126 phototherapy Methods 0.000 abstract description 72
- 230000000694 effects Effects 0.000 abstract description 18
- 238000004020 luminiscence type Methods 0.000 abstract description 18
- 230000005611 electricity Effects 0.000 abstract description 8
- 210000004027 cell Anatomy 0.000 description 9
- -1 polypropylene Polymers 0.000 description 6
- 239000003504 photosensitizing agent Substances 0.000 description 5
- 239000003814 drug Substances 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 239000004814 polyurethane Substances 0.000 description 4
- 239000004698 Polyethylene Substances 0.000 description 3
- 239000004743 Polypropylene Substances 0.000 description 3
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 239000000017 hydrogel Substances 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 229920000573 polyethylene Polymers 0.000 description 3
- 229920001155 polypropylene Polymers 0.000 description 3
- 229920001296 polysiloxane Polymers 0.000 description 3
- 229920002635 polyurethane Polymers 0.000 description 3
- 239000000741 silica gel Substances 0.000 description 3
- 229910002027 silica gel Inorganic materials 0.000 description 3
- ZKHQWZAMYRWXGA-KQYNXXCUSA-J ATP(4-) Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O)[C@@H](O)[C@H]1O ZKHQWZAMYRWXGA-KQYNXXCUSA-J 0.000 description 2
- ZKHQWZAMYRWXGA-UHFFFAOYSA-N Adenosine triphosphate Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)C(O)C1O ZKHQWZAMYRWXGA-UHFFFAOYSA-N 0.000 description 2
- 102000008186 Collagen Human genes 0.000 description 2
- 108010035532 Collagen Proteins 0.000 description 2
- 239000004677 Nylon Substances 0.000 description 2
- 239000002033 PVDF binder Substances 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 238000005452 bending Methods 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- APTUSGMALOMQQL-UHFFFAOYSA-N chembl2029624 Chemical compound O=C1C(OC)=C2C(C(C)=O)=C(C)CC3=C(OC)C(=O)C4=C(O)C=C(OC)C5=C4C3=C2C2=C1C(O)=CC(OC)=C25 APTUSGMALOMQQL-UHFFFAOYSA-N 0.000 description 2
- 229920001436 collagen Polymers 0.000 description 2
- 239000004205 dimethyl polysiloxane Substances 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 238000005286 illumination Methods 0.000 description 2
- 229920000126 latex Polymers 0.000 description 2
- 239000004816 latex Substances 0.000 description 2
- 229920001778 nylon Polymers 0.000 description 2
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 2
- 229920003229 poly(methyl methacrylate) Polymers 0.000 description 2
- 239000004926 polymethyl methacrylate Substances 0.000 description 2
- 229920000306 polymethylpentene Polymers 0.000 description 2
- 239000011116 polymethylpentene Substances 0.000 description 2
- 229920002981 polyvinylidene fluoride Polymers 0.000 description 2
- 229920002725 thermoplastic elastomer Polymers 0.000 description 2
- 230000000472 traumatic effect Effects 0.000 description 2
- OYINILBBZAQBEV-UWJYYQICSA-N (17s,18s)-18-(2-carboxyethyl)-20-(carboxymethyl)-12-ethenyl-7-ethyl-3,8,13,17-tetramethyl-17,18,22,23-tetrahydroporphyrin-2-carboxylic acid Chemical compound N1C2=C(C)C(C=C)=C1C=C(N1)C(C)=C(CC)C1=CC(C(C)=C1C(O)=O)=NC1=C(CC(O)=O)C([C@@H](CCC(O)=O)[C@@H]1C)=NC1=C2 OYINILBBZAQBEV-UWJYYQICSA-N 0.000 description 1
- RBTBFTRPCNLSDE-UHFFFAOYSA-N 3,7-bis(dimethylamino)phenothiazin-5-ium Chemical compound C1=CC(N(C)C)=CC2=[S+]C3=CC(N(C)C)=CC=C3N=C21 RBTBFTRPCNLSDE-UHFFFAOYSA-N 0.000 description 1
- ZGXJTSGNIOSYLO-UHFFFAOYSA-N 88755TAZ87 Chemical compound NCC(=O)CCC(O)=O ZGXJTSGNIOSYLO-UHFFFAOYSA-N 0.000 description 1
- 208000002874 Acne Vulgaris Diseases 0.000 description 1
- 239000004925 Acrylic resin Substances 0.000 description 1
- 229920000178 Acrylic resin Polymers 0.000 description 1
- XMWRBQBLMFGWIX-UHFFFAOYSA-N C60 fullerene Chemical class C12=C3C(C4=C56)=C7C8=C5C5=C9C%10=C6C6=C4C1=C1C4=C6C6=C%10C%10=C9C9=C%11C5=C8C5=C8C7=C3C3=C7C2=C1C1=C2C4=C6C4=C%10C6=C9C9=C%11C5=C5C8=C3C3=C7C1=C1C2=C4C6=C2C9=C5C3=C12 XMWRBQBLMFGWIX-UHFFFAOYSA-N 0.000 description 1
- 229920001661 Chitosan Polymers 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- KZBUYRJDOAKODT-UHFFFAOYSA-N Chlorine Chemical compound ClCl KZBUYRJDOAKODT-UHFFFAOYSA-N 0.000 description 1
- 102000000634 Cytochrome c oxidase subunit IV Human genes 0.000 description 1
- 108090000365 Cytochrome-c oxidases Proteins 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- KGHNSNSWRMJVND-UHFFFAOYSA-N Hypocrellin Natural products COC1=CC(=O)C2=C3C4C(C(C(=O)C)C(C)(O)Cc5c(OC)c(O)c6C(=O)C=C(OC)C(=C13)c6c45)C(=C2O)OC KGHNSNSWRMJVND-UHFFFAOYSA-N 0.000 description 1
- SBMXTMAIKRQSQE-UHFFFAOYSA-N Hypocrellin C Natural products O=C1C=C(OC)C2=C(C3=C45)C(OC)=CC(=O)C3=C(O)C(OC)=C4C(C(C)=O)=C(C)CC3=C5C2=C1C(O)=C3OC SBMXTMAIKRQSQE-UHFFFAOYSA-N 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 108010036176 Melitten Proteins 0.000 description 1
- 239000004696 Poly ether ether ketone Substances 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- 239000004695 Polyether sulfone Substances 0.000 description 1
- 239000004642 Polyimide Substances 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- GUWKQWHKSFBVAC-UHFFFAOYSA-N [C].[Au] Chemical compound [C].[Au] GUWKQWHKSFBVAC-UHFFFAOYSA-N 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- XECAHXYUAAWDEL-UHFFFAOYSA-N acrylonitrile butadiene styrene Chemical compound C=CC=C.C=CC#N.C=CC1=CC=CC=C1 XECAHXYUAAWDEL-UHFFFAOYSA-N 0.000 description 1
- 239000004676 acrylonitrile butadiene styrene Substances 0.000 description 1
- 229920000122 acrylonitrile butadiene styrene Polymers 0.000 description 1
- 229960002749 aminolevulinic acid Drugs 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 230000001139 anti-pruritic effect Effects 0.000 description 1
- 230000001754 anti-pyretic effect Effects 0.000 description 1
- 239000003908 antipruritic agent Substances 0.000 description 1
- 239000002221 antipyretic Substances 0.000 description 1
- 125000000751 azo group Chemical group [*]N=N[*] 0.000 description 1
- 150000004036 bacteriochlorins Chemical class 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 150000004035 chlorins Chemical class 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 150000008049 diazo compounds Chemical class 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003974 emollient agent Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 239000010408 film Substances 0.000 description 1
- 229910003472 fullerene Inorganic materials 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 229910001385 heavy metal Inorganic materials 0.000 description 1
- 230000002439 hemostatic effect Effects 0.000 description 1
- 239000000416 hydrocolloid Substances 0.000 description 1
- VANSZAOQCMTTPB-SETSBSEESA-N hypocrellin Chemical compound C1[C@@](C)(O)[C@@H](C(C)=O)C2=C(OC)C(O)=C3C(=O)C=C(OC)C4=C3C2=C2C3=C4C(OC)=CC(=O)C3=C(O)C(OC)=C21 VANSZAOQCMTTPB-SETSBSEESA-N 0.000 description 1
- YDLBDQPPRTYAIG-UHFFFAOYSA-N hypocrellin A Natural products COC1C2CC(C)(O)C(C(=O)C)C3=C(OC)C(=O)c4c(O)cc(OC)c5c6c(OC)cc(O)c(C1=O)c6c2c3c45 YDLBDQPPRTYAIG-UHFFFAOYSA-N 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- MOFVSTNWEDAEEK-UHFFFAOYSA-M indocyanine green Chemical compound [Na+].[O-]S(=O)(=O)CCCCN1C2=CC=C3C=CC=CC3=C2C(C)(C)C1=CC=CC=CC=CC1=[N+](CCCCS([O-])(=O)=O)C2=CC=C(C=CC=C3)C3=C2C1(C)C MOFVSTNWEDAEEK-UHFFFAOYSA-M 0.000 description 1
- 229960004657 indocyanine green Drugs 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 239000011810 insulating material Substances 0.000 description 1
- 239000002085 irritant Substances 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- VDXZNPDIRNWWCW-JFTDCZMZSA-N melittin Chemical compound NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(N)=O)CC1=CNC2=CC=CC=C12 VDXZNPDIRNWWCW-JFTDCZMZSA-N 0.000 description 1
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 1
- 229910052753 mercury Inorganic materials 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 229960000907 methylthioninium chloride Drugs 0.000 description 1
- 210000003470 mitochondria Anatomy 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 239000002077 nanosphere Substances 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 239000006072 paste Substances 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 150000003003 phosphines Chemical class 0.000 description 1
- 238000000554 physical therapy Methods 0.000 description 1
- 229920002492 poly(sulfone) Polymers 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 239000004417 polycarbonate Substances 0.000 description 1
- 229920000515 polycarbonate Polymers 0.000 description 1
- 229920000728 polyester Polymers 0.000 description 1
- 229920006393 polyether sulfone Polymers 0.000 description 1
- 229920002530 polyetherether ketone Polymers 0.000 description 1
- 229920001721 polyimide Polymers 0.000 description 1
- 229920000098 polyolefin Polymers 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 239000004810 polytetrafluoroethylene Substances 0.000 description 1
- 229920001343 polytetrafluoroethylene Polymers 0.000 description 1
- 239000004800 polyvinyl chloride Substances 0.000 description 1
- 229920000915 polyvinyl chloride Polymers 0.000 description 1
- 150000004032 porphyrins Chemical class 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 150000003233 pyrroles Chemical class 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- BQJKVFXDDMQLBE-UHFFFAOYSA-N shiraiachrome A Natural products COC1=C2C3=C(OC)C=C(O)C4=C3C3=C5C(CC(C)(O)C(C(C)=O)C3=C(OC)C4=O)=C(OC)C(=O)C(C(O)=C1)=C25 BQJKVFXDDMQLBE-UHFFFAOYSA-N 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N5/0601—Apparatus for use inside the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N5/0613—Apparatus adapted for a specific treatment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N2005/0635—Radiation therapy using light characterised by the body area to be irradiated
- A61N2005/0643—Applicators, probes irradiating specific body areas in close proximity
- A61N2005/0645—Applicators worn by the patient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N2005/065—Light sources therefor
- A61N2005/0651—Diodes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N2005/065—Light sources therefor
- A61N2005/0651—Diodes
- A61N2005/0653—Organic light emitting diodes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N2005/0658—Radiation therapy using light characterised by the wavelength of light used
- A61N2005/0662—Visible light
Abstract
The application discloses a specific structure of a photomedical device, wherein the photomedical device is provided with a functional module on a substrate, the functional module comprises an electro-deformation unit, an isolation layer and a light-emitting unit arranged on the isolation layer, the electro-deformation unit is provided with an electro-deformation layer and a first electrode layer and a second electrode layer which are used for driving the electro-deformation layer, when the electro-deformation layer is not electrified, the electro-deformation layer does not deform, the appearance of the phototherapy device is kept unchanged, and the phototherapy device is convenient to place in a patient; when the phototherapy device was put into the patient internally, first electrode and second electrode circular telegram made the electricity generate the deformation layer start, and the deformation takes place for the electricity generate the deformation layer, drives the isolation layer on and the luminescence unit on to remove to one side of keeping away from the substrate on the radial direction of substrate, can make luminescence unit and the internal affected part interval of patient reduce, guarantees the effect of phototherapy.
Description
Technical Field
The application relates to the technical field of optical medical treatment, and particularly discloses an optical medical treatment device.
Background
Phototherapy is a physical therapy method for treating diseases by using the radiant energy of light. The light source that uses among the present phototherapy process has radium-shine, fluorescent lamp, but this type of light source device is not portable or dress to radium-shine power is too strong, can harm normal tissue, and fluorescent lamp contains heavy metal such as lead, mercury, has certain potential safety hazard to internal treatment, and radium-shine light source and fluorescent light source's luminous homogeneity is relatively poor in addition, is unfavorable for the great affected part treatment of area. For current Light Emitting Diode (LED) light sources or Organic Light Emitting Diode (OLED) light sources. When the existing phototherapy equipment is used for treatment, the phototherapy effect is poor, and improvement is urgently needed.
Disclosure of Invention
In view of the above-mentioned drawbacks and deficiencies of the prior art, the present application is directed to providing a phototherapeutic device that effectively improves the effectiveness of phototherapy compared to the prior art.
A photomedical device, comprising: a substrate and at least one functional module formed on the substrate; the functional module includes: at least one electrostrictive element formed on the substrate; the isolating layer is formed on one side, relatively far away from the base material, of the electrostrictive element; and at least one light emitting cell disposed on the isolation layer; the electro-deformation unit includes: a first electrode layer, an electro-deformable layer and a second electrode layer formed on the substrate in this order.
According to the technical scheme provided by the embodiment of the application, two adjacent light-emitting units are connected through a stretchable lead, the stretchable lead is made of a high polymer micro-tube, and an elastic conductor formed by liquid metal is filled in the micro-tube or a curve-shaped conductor made of Ag, Al, Au, Cu, a carbon nano-tube or graphene.
According to the technical scheme provided by the embodiment of the application, the insulating layer is formed on the base material, and the electrostrictive unit is formed on the insulating layer.
According to the technical scheme provided by the embodiment of the application, each light-emitting unit is coated with a scattering coating, and/or the functional module is coated with a skin-friendly material layer.
According to the technical scheme provided by the embodiment of the application, one end of the base material is provided with a functional module; or the functional module is arranged around the side wall of the base material along the circumferential direction of the side wall of the base material; or the functional modules are continuously distributed along the circumferential direction of the substrate side wall and distributed in local areas on the substrate side wall; or the functional modules are distributed at intervals along the circumferential direction of the side wall of the base material; or the functional modules are spirally distributed along the circumferential direction of the side wall of the base material.
According to the technical scheme provided by the embodiment of the application, a plurality of mutually separated functional modules are formed on the base material and distributed along the axial direction of the base material.
According to the technical scheme provided by the embodiment of the application, the mutually separated functional modules can emit light rays with different intensities and different colors.
According to the technical scheme provided by the embodiment of the application, the substrate is provided with an inner cavity allowing the circuit to penetrate through.
According to the technical scheme provided by the embodiment of the application, the light-emitting unit is an OLED unit and/or an LED lamp bead.
According to the technical scheme provided by the embodiment of the application, the deformation amount of the electro-deformation layer meets the constraint of the following formula: e ═ SET + d E wherein: wherein SEThe elastic compliance coefficient when the electric field intensity (E) is constant, T is stress, d is a piezoelectric strain constant, and E is the electric field intensity; preferably, the electric field strength E is in the range of 0.1-20V.
According to the technical scheme provided by the embodiment of the application, at least one axial groove extending along the axis of the base material is formed in the side wall of the base material, and an axial plate capable of moving back and forth along the axial groove is matched and connected in the axial groove; a soft substrate is connected between the axial plate and one end of the axial groove on the same side, and a functional module is formed on the soft substrate; when the free end of the axial plate is driven to move along the axial groove to the side far away from the side applying the driving force, the soft substrate is deformed.
In summary, the present application discloses a specific structure of a photomedical device. The photomedical device provided by the embodiment is characterized in that a functional module is designed on a base material, the functional module comprises an electrostrictive unit, an isolation layer and a light-emitting unit arranged on the isolation layer, the electrostrictive unit is provided with an electrostrictive layer, a first electrode layer and a second electrode layer, the first electrode layer and the second electrode layer are used for driving the electrostrictive layer, and when the electrostrictive layer is not electrified, the electrostrictive layer does not deform, so that the appearance of the phototherapy device is kept unchanged, and the phototherapy device is convenient to place in a patient; when the phototherapy device was put into the patient internally, first electrode and second electrode circular telegram made the electricity generate the deformation layer start, and the deformation takes place for the electricity generate the deformation layer, drives the isolation layer on and the luminescence unit on to remove to one side of keeping away from the substrate on the radial direction of substrate, can make luminescence unit and the internal affected part interval of patient reduce, guarantees the effect of phototherapy.
Furthermore, the electro-deformation layer deforms, and when the isolation layer is provided with more than two light-emitting units, the two adjacent light-emitting units are driven to be away from each other, so that the actual action range of the phototherapy can be enlarged by the light-emitting units on the isolation layer, and the uniformity of the phototherapy can be improved.
Drawings
Other features, objects and advantages of the present application will become more apparent upon reading of the following detailed description of non-limiting embodiments thereof, made with reference to the accompanying drawings in which:
fig. 1 is a schematic cross-sectional view of a phototherapy apparatus;
in FIG. 2a, the functional modules of the phototherapy apparatus are distributed (not deformed) around the whole circumferential region of the sidewall of the substrate;
in fig. 2b1, the functional modules of the phototherapy device are distributed (undeformed) around a local area of the substrate;
FIG. 2b2 is a schematic structural view (not deformed) of the left side view of the phototherapy apparatus in FIG. 2b 1;
in FIG. 2c, the functional modules of the phototherapy device are circumferentially spaced around the sidewall of the substrate (not deformed);
FIG. 2d shows the functional modules of the phototherapy apparatus in FIG. 2a distributed (deformed) around the whole area of the substrate;
FIG. 2e shows the functional module of the phototherapy device of FIG. 2b1 surrounding a local area of the substrate (deformation);
FIG. 2f is a schematic structural view (deformation) of the left side view of the phototherapy apparatus in FIG. 2 c;
FIG. 2g shows the functional modules of the phototherapy apparatus spirally distributed (undeformed) around the sidewall of the substrate;
FIG. 3a is a side view of the insulating layer of FIG. 2a on the sidewall of the substrate;
FIG. 3b illustrates in a side view the arrangement of the corresponding insulating layers of FIG. 2b1 on the substrate side wall;
FIG. 3c illustrates, in a side view, the arrangement of the corresponding insulating layers of FIG. 2c on the substrate side walls;
FIG. 3d is a front view of the insulating layer corresponding to FIG. 2g on the sidewall of the substrate;
the unpowered state in the phototherapy device shown in fig. 4;
fig. 5a shows a schematic cross-sectional view of a phototherapy apparatus (without deformation);
fig. 5b shows a schematic cross-sectional view (modification) of the phototherapy apparatus;
FIG. 6a shows a preferred embodiment of a substrate in a phototherapy device (initial state);
FIG. 6b shows a preferred embodiment of a substrate in a phototherapy device (in use);
fig. 7 is a schematic cross-sectional view of a phototherapy apparatus.
In the figure: 10. a functional module; 10a, a first functional module; 10b, a second functional module; 10c, a third functional module; 11. an electro-deformation unit; 111. a first electrode layer; 112. an electro-deformable layer; 113. a second electrode layer; 12. an isolation layer; 13. a light emitting unit; 14. an insulating layer; 15. a layer of skin-friendly material; 20. a substrate; 21. an axial slot; 22. an axial plate; 23. a flexible substrate.
Detailed Description
The present application will be described in further detail with reference to the following drawings and examples. It is to be understood that the specific embodiments described herein are merely illustrative of the relevant invention and not restrictive of the invention. It should be noted that, for convenience of description, only the portions related to the present invention are shown in the drawings.
It should be noted that the embodiments and features of the embodiments in the present application may be combined with each other without conflict. The present application will be described in detail below with reference to the embodiments with reference to the attached drawings.
The present embodiment specifically shows a specific structure of the photomedical device.
Referring to fig. 1, the photomedical device includes:
a substrate 20 and at least one functional module 10 formed on the substrate;
the functional module 10 includes:
at least one electrostrictive element 11 formed on the substrate;
the isolating layer 12 is formed on the side, far away from the base material, of the electrostrictive element 11;
and at least one light emitting cell 13 disposed on the isolation layer;
the electro-deformation unit 11 includes: a first electrode layer 111, an electro-deformable layer 112 and a second electrode layer 113 formed in this order on a substrate.
Wherein the content of the first and second substances,
the base material 20, which is a supporting member of the phototherapy device in the present embodiment, is used for installing the functional module 10 thereon, and optionally, the base material is: polypropylene (PP), thermoplastic elastomers (e.g., TPE, TPR), or silicone. Optionally, the structure of the substrate 20 is a columnar structure, and the shape of the cross section thereof is not limited herein, and is preferably a columnar structure or a sheet-like structure. Optionally, the substrate has a lumen for allowing the wire to pass through, so as to guide the power supply wire to pass through, and optionally, the lumen may be a structure extending along the axial direction and passing through two ends of the substrate; or may be a structure that does not extend in the axial direction thereof but still realizes a guide line, such as: so that one end of the circuit is exposed on the sidewall of the substrate and the other end thereof penetrates through the other end of the substrate. Alternatively, the substrate may be a cellulose hose, which is capable of performing both of the above functions.
Wherein, functional module 10 is formed on the substrate lateral wall, can obtain the different implementation structures of phototherapy device, specifically as follows:
such as: the functional modules 10 are arranged around the substrate 20 side wall in the circumferential direction of the substrate side wall, as shown in fig. 2 a. Under this design, phototherapy device is whole to be the column structure, can carry out phototherapy effectively to the internal annular wound of patient when it gets into the patient.
Such as: the functional modules 10 are distributed continuously along the circumferential direction of the side wall of the substrate 20 and they are distributed in the local areas on the side wall of the substrate, as shown in fig. 2b1 and fig. 2b 2. Preferably, in practical applications, the coverage area of the functional module 10 can be designed according to practical specification dimensions. Can be applied to local affected parts in the body of a patient.
For another example: the functional modules 10 are spaced along the circumferential direction of the sidewall of the substrate 20, as shown in fig. 2 c. In this embodiment, the functional modules 10 are distributed in a circular array on the sidewall of the substrate, and can be applied to a plurality of discrete affected parts in the patient.
For another example: the functional modules 10 are spirally distributed along the circumferential direction of the side wall of the base material 20. As shown in fig. 2 g. In this embodiment, the functional modules 10 are spirally distributed on the sidewall of the substrate, and can be applied to the affected parts with similar distribution in the body of the patient.
The functional module 10 includes:
at least one electrostrictive element 11 formed on the wall of the substrate side 10;
the isolating layer 12 is formed on the side, far away from the base material, of the electrostrictive element 11;
and at least one light emitting cell 13 disposed on the isolation layer.
Wherein:
the electro-deformation unit 11 includes: a first electrode 111, an electro-deformable layer 112, and a second electrode layer 113 formed in this order on the insulating layer;
wherein the first electrode 111 and the second electrode 113 are used for electro-deformationLayer 112 supplies current. When the electrorheological layer is not electrified, the electrorheological layer does not deform, so that the shape of the phototherapy device is kept unchanged, and the phototherapy device is conveniently placed in a patient body or applied with external treatment; when the phototherapy device was put into the patient internally, first electrode and second electrode circular telegram made the electricity generate the deformation layer start, and the deformation takes place for the electricity generate the deformation layer, drives the isolation layer on and the luminescence unit on to remove to one side of keeping away from the substrate on the radial direction of substrate, can make luminescence unit and the internal affected part interval of patient reduce, guarantees the effect of phototherapy. Optionally, the material of the electrostrictive layer is: at least one of acrylic resin material, carbon nanotube or PVDF. Specifically, the amount of deformation of the electro-deformable layer complies with the constraint of the following formula: e ═ SET + d E wherein: wherein SEThe elastic compliance coefficient when the electric field intensity (E) is constant, T is stress, d is a piezoelectric strain constant, and E is the electric field intensity; preferably, the electric field strength E is in the range of 0.1-20V.
In fig. 2a, the functional modules of the phototherapy device are distributed (undeformed) around the entire circumferential area of the sidewall of the substrate.
Fig. 2d shows the functional modules of the phototherapy device of fig. 2a distributed (deformed) around the whole area of the substrate.
In fig. 2b1, the functional modules of the phototherapy device are distributed (undeformed) around a local area of the substrate.
Fig. 2e shows the functional module of the phototherapy device of fig. 2b1 surrounding a local area of the substrate (deformation).
In fig. 2c, the functional modules of the phototherapy device are circumferentially spaced around the sidewall of the substrate (not deformed).
Fig. 2f shows a schematic structural view (deformation) of the left side view of the phototherapy apparatus in fig. 2 c.
The isolation layer 12 is used for isolating and protecting the electrostrictive element, so that the electrostrictive element is prevented from being damaged, and the light-emitting element is embedded on the electrostrictive element. Optionally, the isolation layer has elasticity, and maintains an original shape in a non-energized starting state of the electro-deformation unit; when the electrostrictive cell is activated, the electrostrictive cell expands to cause the isolation layer to change its shape, as shown in fig. 2d, 2e, and 2 f. And then the light-emitting unit embedded on the base material is driven to move away from the base material. Specifically, the isolation layer may be made of: insulating materials, such as: latex, polyurethane, and the like.
In a preferred embodiment, the light emitting unit 13 is an OLED and/or LED lamp bead. When deformation takes place for the electrorheological layer, drive the isolation layer on and OLED and/or LED lamp pearl on it on the radial direction of substrate and remove to the one side of keeping away from the substrate, can make luminous unit and the internal affected part interval of patient reduce, guarantee the effect of phototherapy.
Furthermore, the electro-deformable layer 112 deforms, and the two adjacent light-emitting units 13 are driven to be away from each other in the axial direction of the substrate 20, so that the light-emitting units 13 on the electro-deformable layer can expand the actual action range of the phototherapy and improve the uniformity of the phototherapy. Optionally, the power supply lines for the OLED and/or LED beads may extend through the sidewall of the substrate and along the interior cavity of the substrate.
In a preferred embodiment, each of the light emitting cells 13 is coated with a scattering coating. The design of scattering coating can make OLED unit and/or the light that LED lamp pearl emitted act on patient's affected part more evenly, realizes better treatment.
Optionally, two adjacent light emitting units are connected by a stretchable wire. The stretchable lead is made of a high polymer micro-tube, and an elastic conductor formed by liquid metal or a curve-shaped conductor made of Ag, Al, Au, Cu, a carbon nano-tube or graphene is filled in the micro-tube.
Before the deformation of the single isolation layer, the distance d between two adjacent light emitting units is 0.3-6mm, for example, 0.6 mm.
After deformation, the distance between two adjacent light-emitting units can be 1-3 times of d.
In a preferred embodiment, an insulating layer 14 is formed on the substrate 20, and an electrostrictive element is formed on the insulating layer.
Wherein, be formed with the insulating layer on the lateral wall of substrate, the design of insulating layer has realized the electrical isolation between substrate and the electrodeformation unit, strengthens the reliability in the phototherapy device use in this embodiment. The distribution of the insulating layer on the side wall of the substrate is not limited, and the insulating layer has various implementable forms corresponding to the arrangement of the electrostrictive unit:
such as: the insulating layer is disposed around the substrate sidewall in a circumferential direction of the substrate sidewall, as shown in fig. 3 a. In this embodiment, the insulating layer is annularly disposed on the sidewall of the substrate.
For another example: the insulating layer is continuously distributed along the circumferential direction of the substrate sidewall and distributed in a local area on the substrate sidewall, as shown in fig. 3 b. In this embodiment, the insulating layer is disposed on the sidewall of the substrate in a fan shape.
For another example: the insulating layers are distributed at intervals along the circumferential direction of the substrate side wall, as shown in fig. 3 c. In this embodiment, the insulating layers are disposed in a circular array on the sidewall of the substrate. Can be applied to a plurality of discrete affected parts in the body of a patient.
For another example: the insulating layers are spirally distributed along the circumferential direction of the side wall of the base material. As shown in fig. 3 d. In this embodiment, the electrostrictive elements are spirally disposed on the sidewall of the substrate, and can be applied to affected parts that are similarly disposed in the body of a patient.
In a preferred embodiment, the functional module is externally coated with a layer 15 of skin-friendly material.
The design of close skin material layer can reduce the foreign body sensation after phototherapy device gets into the human body, and the patient that the reinforcing was in the use experiences. Meanwhile, the light medical treatment device can realize the treatment of external non-traumatic skin parts and can also realize the treatment of external traumatic parts and internal diseases. The skin-friendly material can be prepared from the following materials: latex, silica gel, Polydimethylsiloxane (PDMS), silica gel, Collagen (Collagen), silicone Hydrogel (Hydrogel), Hydrogel (hydrocolloids), Polyurethane (Polyurethane, PU), Polymethylmethacrylate (PMMA), polymethylpentene polymer (PMP), Polyethylene (PE), polycarbonate, polystyrene, acrylonitrile butadiene styrene, polyolefin, polyamide, polyvinyl chloride, polyethylene, polypropylene, nylon, polyester, silicone, polyimide, polytetrafluoroethylene, polyethersulfone, polysulfone, polyetheretherketone, chitosan, pectin, gelatin, nylon, fiber, and the like.
Further, the skin-friendly material layer can contain drugs and/or photosensitizers;
the medicinal layer may also contain antibiotic, analgesic, antipyretic, antimicrobial, antibacterial, antiallergic, acne medicine, antiinflammatory, hemostatic, vitamin, anti-irritant, antipruritic, emollient, photosensitizer, etc., preferably photosensitizer.
The form of the medicine can be paste, cream, gel, powder, liquid, film, or patch.
Also for the photosensitive particles we can use the following materials to make up the photosensitizer with the skin-friendly materials mentioned above, for example: a plurality of condensed ring azo and diazo compounds, aminolevulinic acid, indocyanine green, methylene blue, hypocrellin A and derivatives thereof, hypocrellin B and derivatives thereof, melittin, gold-carbon nanospheres, carbon nanotubes, phosphines, fullerenes, chlorins, bacteriochlorins and modified compositions thereof, pyrroles and modified compositions thereof, porphyrins and modified compositions thereof, phthalocyanines and modified compositions thereof, chlorine e6, monochloro, chlorine or benzotetrahydroxyphenyl chloride.
Through the matching of the skin-friendly material, the medicine and the photosensitizer, the treatment effect can be effectively improved and the treatment course can be shortened aiming at different lesion areas.
In a preferred embodiment, the substrate is formed with a plurality of mutually spaced functional modules 10 distributed along the axial direction of the substrate.
In this embodiment, there may be a plurality of functional modules 10, and each functional module 10 can be controlled individually.
As shown in fig. 4, the functional modules 10 in fig. 4 are arranged around the substrate, and the functional modules 10 are distributed along the axial direction of the substrate. Specifically a first functional module 10a, a second functional module 10b and a third functional module 10c as shown. Under the actual application scene, the functional module 10 that puts into operation can be adjusted according to the regional regulation of the internal affected part of patient, also can adjust the illumination intensity of different functional modules 10 for the use of phototherapy device more can adapt to actual scene in this embodiment.
The light emitting unit between the first functional module 10a and the second functional module 10b in fig. 4 may be connected by a stretchable wire; accordingly, the light emitting unit between the second functional module 10b and the third functional module 10c in fig. 4 may be connected by a stretchable wire.
Preferably, a gap is formed between two mutually separated functional modules to reserve enough space for two adjacent functional modules to deform in an electrifying manner.
In a preferred embodiment, the mutually separated functional modules 10 are capable of emitting light of different intensities and different colors. In particular, description of the phototherapy effect of different colors of light:
the irradiation depth of the yellow green light with the wave band of 510 nm-590 nm is between the blue light and the red light, so that the dredging and the expansion of the capillary vessel in the skin depth can be promoted, the resistance of cells is enhanced, and the treatment effect of the affected part is accelerated.
Red light with a waveband of 590-810 nm can enable mitochondria to release cytochrome c oxidase, increase adenosine triphosphate, and enable cells to provide energy by utilizing the adenosine triphosphate, so that the metabolism of the cells is promoted; meanwhile, the red light irradiation heats molecules in the blood vessel, regulates the blood vessel expansion and improves the blood circulation.
The blue light irradiation of the 440-510 nm wave band can be used for relieving pain and swelling caused by inflammation.
The method for regulating and controlling the illumination intensity of the OLED light source comprises the following steps:
input current or voltage are adjusted through the control module to realize the phototherapy of different intensity, be adapted to the disease district of different severity.
Preferably in another embodiment, in which the functional modules are locally distributed on the substrate as in the embodiment shown in the above-mentioned fig. 2b1, 2b2, the electrostrictive element 11 may be preferably designed to include: a first electrode 111, a first electro-deformable layer 112a, a second electro-deformable layer 112b, and a second electrode layer 113 formed in this order on the insulating layer.
Wherein:
a first electrode 111 and a second electrode 113 for supplying current to the first and second electro- deformable layers 112a and 112 b.
When the electrorheological layer is not electrified, the electrorheological layer does not deform, the shape of the phototherapy device is kept unchanged, and the phototherapy device is convenient to place in a patient body or apply external treatment.
When the phototherapy device is placed in a patient or treated outside the patient, the first and second electrodes are energized such that the first and second electro- deformable layers 112a, 112b are activated and the first and second electro- deformable layers 112a, 112b begin to deform.
In an application scenario, it is preferable that the first electro-deformable layer 112a and the second electro-deformable layer 112b are made of the same material, that is, the two layers are stacked, so that the expansion effect of the phototherapy device in this embodiment is better.
In another application scenario, the first electro-deformable layer 112a and the second electro-deformable layer 112b may be made of different materials, such as:
the first electro-deformable layer 112a is characterized by electrical shrinkage, and may be made of: a carbon nanotube; the second electro-deformable layer 112b is characterized by being expanded when energized, and may be made of: PVDF. After circular telegram inflation, considering first electro morphism layer and second electro morphism layer characteristic difference, the effect that finally forms can refer to fig. 5a and fig. 5b and shows, also the electro morphism unit 11 has formed the bending effect, drives to be formed at isolation layer 12, luminescence unit 13 and to the one side bending that is close to the affected part, can make luminescence unit and the internal affected part interval of patient reduce, guarantees the effect of phototherapy.
Wherein: FIG. 5a is a state of no deformation; fig. 5b shows the deformed state, which is a flexible substrate, and can transmit the follow-up deformation.
In the embodiment shown in fig. 2c, the functional modules are distributed at intervals in the circumferential direction of the substrate, and the electrostrictive element 11 in any one of the functional modules, any two adjacent functional modules, or any three adjacent functional modules includes: the first electrode 111, the first electro-deformable layer 112a, the second electro-deformable layer 112b, and the second electrode layer 113, which are sequentially formed on the insulating layer, can also generate the deformation effect shown in fig. 5 b.
In addition, when the substrate is a sheet-like structure and one side of the substrate is provided with a functional module, the electrostrictive element 11 may be configured to include: the first electrode 111, the first electro-deformable layer 112a, the second electro-deformable layer 112b, and the second electrode layer 113, which are sequentially formed on the insulating layer, can also generate the deformation effect shown in fig. 5 b.
Please refer to fig. 6a and 6b for another preferred embodiment of the phototherapy device.
The side wall of the base material 20 is provided with at least one axial groove 21 extending along the axis of the base material, the axial groove 21 is internally matched with an axial plate 22 capable of reciprocating along the axial groove, a soft substrate 23 (such as a silica gel material) is connected between the axial plate 22 and one end of the axial groove 21 positioned on the same side, the soft substrate 23 is formed with a functional module 10, and when the free end of the axial plate 22 is driven to move along the axial groove 21 to the side far away from the side where the driving force is applied, the soft substrate 23 deforms, such as a bulge shape.
In the specific structure of the phototherapy device shown in fig. 6a, the axial plate is in the initial state, and the soft substrate is in the initial state, that is: and keeping the flatness. When the phototherapy apparatus is used in this state: if the electrorheological layer is not electrified, the electrorheological layer does not deform, so that the shape of the phototherapy device is kept unchanged, and the phototherapy device is convenient to place in a patient body; when the phototherapy device was put into the patient internally, first electrode and second electrode circular telegram made the electricity generate the deformation layer start, and the deformation takes place for the electricity generate the deformation layer, drives the isolation layer on and the luminescence unit on to remove to one side of keeping away from the substrate on the radial direction of substrate, can make luminescence unit and the internal affected part interval of patient reduce, guarantees the effect of phototherapy. Furthermore, the deformation takes place for the electrodeformation layer, if possess more than two luminescence units on the isolation layer, drive and keep away from each other between the two adjacent luminescence units, can make the actual effect scope that the luminescence unit on it can enlarge the phototherapy, also can improve the even degree of phototherapy.
In the specific structure of the phototherapy device shown in fig. 6b, when the first electrode and the second electrode are energized to activate the electro-deformable layer and the electro-deformable layer is deformed, the flexible substrate 23 is deformed, such as to be raised, when the free end of the axial plate 22 is driven to move along the axial slot 21 to a side away from the side to which the driving force is applied. Compared with any of the above embodiments, the soft substrate is designed such that the functional module can be brought closer to the affected part in the vicinity of the circumferential direction of the base material by the bulge-like structure; on the other hand, when the soft substrate is pushed to be gathered to the side to which the driving force is applied, the functional module can be brought closer to the affected part near the distal end of the base material.
The soft substrate and the axial plate can be integrally formed, so that hardness values are distinguished from each other, the hardness of the soft substrate is smaller than that of the axial plate, and the soft substrate has the characteristic of flexible deformation.
To ensure that the units on the functional module are reliably powered during the movement of the drive shaft plate, stretchable leads may be used to power the units on the functional module.
It should be noted that fig. 6a and 6b are only schematic diagrams, and the length direction and proportional relationship between the axial plate and the soft substrate are not limited by the drawings.
Please refer to another preferred embodiment of the phototherapy device shown in fig. 7.
In any of the above embodiments, a functional module may be provided at one end of the base material.
The specific implementation structure of the functional module in any of the above embodiments can be applied to this embodiment.
Different from each embodiment, locate the functional module of substrate tip, can carry out the phototherapy to the affected part that is located substrate tip one side, and after the functional module circular telegram who locates the substrate tip warp, drive the isolation layer on and the luminescence unit on it and move to one side of keeping away from the substrate on the axial direction of substrate, can make the luminescence unit and the internal affected part interval of patient reduce, guarantee the effect of phototherapy. Furthermore, the deformation takes place for the electrodeformation layer, if possess the luminescence unit more than two on the isolation layer, drive and keep away from each other between the two adjacent luminescence units, can make the luminescence unit on it can enlarge the actual effect scope of phototherapy, also can improve the even degree of local phototherapy.
The above description is only a preferred embodiment of the application and is illustrative of the principles of the technology employed. It will be appreciated by a person skilled in the art that the scope of the invention as referred to in the present application is not limited to the embodiments with a specific combination of the above-mentioned features, but also covers other embodiments with any combination of the above-mentioned features or their equivalents without departing from the inventive concept. For example, the above features may be replaced with (but not limited to) features having similar functions disclosed in the present application.
Claims (10)
1. An photomedical device, comprising:
a substrate and at least one functional module formed on the substrate;
the functional module includes:
at least one electrostrictive element formed on the substrate;
the isolating layer is formed on one side, relatively far away from the base material, of the electrostrictive element;
and at least one light emitting cell disposed on the isolation layer;
the electro-deformation unit includes: a first electrode layer, an electro-deformable layer and a second electrode layer formed on the substrate in this order.
2. A photomedical device according to claim 1, wherein:
the two adjacent light-emitting units are connected through a stretchable lead, the stretchable lead is made of a high-molecular polymer micro-tube, and an elastic conductor formed by liquid metal or a curve-shaped conductor made of Ag, Al, Au, Cu, a carbon nano-tube or graphene is filled in the micro-tube.
3. A photomedical device according to claim 1, wherein:
an insulating layer is formed on the substrate, and an electro-deformation unit is formed on the insulating layer.
4. A photomedical device according to claim 1, wherein:
and a scattering coating is coated on each light-emitting unit, and/or a skin-friendly material layer is coated outside the functional module.
5. A photomedical device according to any one of claims 1 to 4, wherein:
one end of the substrate is provided with a functional module.
Or the functional module is arranged around the side wall of the base material along the circumferential direction of the side wall of the base material;
or the functional modules are continuously distributed along the circumferential direction of the substrate side wall and distributed in local areas on the substrate side wall;
or the functional modules are distributed at intervals along the circumferential direction of the side wall of the base material;
or the functional modules are spirally distributed along the circumferential direction of the side wall of the base material.
6. A photomedical device according to any one of claims 1 to 4, wherein:
the substrate is provided with a plurality of mutually separated functional modules distributed along the axial direction of the substrate.
7. The photomedical device of claim 6, wherein:
the mutually separated functional modules can emit light rays with different intensities and different colors.
8. A photomedical device according to any one of claims 1 to 4, wherein: the substrate has an inner cavity allowing the wire to pass through; and/or the light-emitting unit is an OLED unit and/or an LED lamp bead.
9. A photomedical device according to any one of claims 1 to 4, wherein: the amount of deformation of the electro-deformable layer complies with the constraints of the following formula:
e=SE*T+d*E
wherein: wherein SEThe elastic compliance coefficient when the electric field intensity (E) is constant, T is stress, d is a piezoelectric strain constant, and E is the electric field intensity;
preferably, the electric field strength E is in the range of 0.1-20V.
10. A photomedical device according to any one of claims 1 to 4, wherein:
the side wall of the base material is provided with at least one axial groove extending along the axis of the base material, and an axial plate capable of reciprocating along the axial groove is matched and connected in the axial groove;
a soft substrate is connected between the axial plate and one end of the axial groove on the same side, and a functional module is formed on the soft substrate;
when the free end of the axial plate is driven to move along the axial groove to the side far away from the side applying the driving force, the soft substrate is deformed.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202111049756.1A CN113730825B (en) | 2021-09-08 | 2021-09-08 | Phototherapy device |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202111049756.1A CN113730825B (en) | 2021-09-08 | 2021-09-08 | Phototherapy device |
Publications (2)
Publication Number | Publication Date |
---|---|
CN113730825A true CN113730825A (en) | 2021-12-03 |
CN113730825B CN113730825B (en) | 2024-04-02 |
Family
ID=78736987
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202111049756.1A Active CN113730825B (en) | 2021-09-08 | 2021-09-08 | Phototherapy device |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN113730825B (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113975656A (en) * | 2021-12-13 | 2022-01-28 | 固安翌光科技有限公司 | Phototherapy device for treating neonatal jaundice |
CN114028731A (en) * | 2021-12-10 | 2022-02-11 | 固安翌光科技有限公司 | Waist shaping phototherapy device |
CN114082109A (en) * | 2021-12-21 | 2022-02-25 | 固安翌光科技有限公司 | Shape-adaptive phototherapy wearing article |
Citations (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE8116045U1 (en) * | 1981-05-29 | 1982-11-04 | Siemens AG, 1000 Berlin und 8000 München | HANDLE FOR THERAPY ELECTRODES |
WO2005025671A1 (en) * | 2003-09-17 | 2005-03-24 | Djalma Luiz Rodrigues | A phototherapy equipment, particularly for the treatment of hyperbilirubinemia |
WO2007059988A1 (en) * | 2005-11-24 | 2007-05-31 | Femeda Limited | A compressible device |
KR20130110365A (en) * | 2012-03-29 | 2013-10-10 | 주식회사로케트전기 | Dermal patch for light theraphy |
CN206295508U (en) * | 2016-08-30 | 2017-07-04 | 宁夏众联数据服务有限公司 | A kind of embedded devices electronic therapeutic instrument |
CN107258549A (en) * | 2017-06-15 | 2017-10-20 | 吴平顺 | Multi-functional sick cub isolation care facility |
CN108969898A (en) * | 2018-06-29 | 2018-12-11 | 河南省宇安医疗科技开发有限公司 | The impedance match optical power control circuit of Pain Therapy by Laser Diode instrument |
WO2019097590A1 (en) * | 2017-11-14 | 2019-05-23 | 錦隆 後藤 | Treatment device |
CN111840809A (en) * | 2020-07-22 | 2020-10-30 | 固安翌光科技有限公司 | Optical medical device |
CN212141169U (en) * | 2019-11-15 | 2020-12-15 | 北京大学深圳研究生院 | Phototherapy skin care instrument based on alternating current electroluminescent device |
-
2021
- 2021-09-08 CN CN202111049756.1A patent/CN113730825B/en active Active
Patent Citations (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE8116045U1 (en) * | 1981-05-29 | 1982-11-04 | Siemens AG, 1000 Berlin und 8000 München | HANDLE FOR THERAPY ELECTRODES |
WO2005025671A1 (en) * | 2003-09-17 | 2005-03-24 | Djalma Luiz Rodrigues | A phototherapy equipment, particularly for the treatment of hyperbilirubinemia |
WO2007059988A1 (en) * | 2005-11-24 | 2007-05-31 | Femeda Limited | A compressible device |
KR20130110365A (en) * | 2012-03-29 | 2013-10-10 | 주식회사로케트전기 | Dermal patch for light theraphy |
CN206295508U (en) * | 2016-08-30 | 2017-07-04 | 宁夏众联数据服务有限公司 | A kind of embedded devices electronic therapeutic instrument |
CN107258549A (en) * | 2017-06-15 | 2017-10-20 | 吴平顺 | Multi-functional sick cub isolation care facility |
WO2019097590A1 (en) * | 2017-11-14 | 2019-05-23 | 錦隆 後藤 | Treatment device |
CN108969898A (en) * | 2018-06-29 | 2018-12-11 | 河南省宇安医疗科技开发有限公司 | The impedance match optical power control circuit of Pain Therapy by Laser Diode instrument |
CN212141169U (en) * | 2019-11-15 | 2020-12-15 | 北京大学深圳研究生院 | Phototherapy skin care instrument based on alternating current electroluminescent device |
CN111840809A (en) * | 2020-07-22 | 2020-10-30 | 固安翌光科技有限公司 | Optical medical device |
Non-Patent Citations (1)
Title |
---|
梁瑞政: "光功能客体/LDHs插层复合材料的构筑及其性能研究", 中国优秀硕士毕业论文 * |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114028731A (en) * | 2021-12-10 | 2022-02-11 | 固安翌光科技有限公司 | Waist shaping phototherapy device |
CN114028731B (en) * | 2021-12-10 | 2024-01-26 | 固安翌光科技有限公司 | Waist shaping phototherapy device |
CN113975656A (en) * | 2021-12-13 | 2022-01-28 | 固安翌光科技有限公司 | Phototherapy device for treating neonatal jaundice |
CN113975656B (en) * | 2021-12-13 | 2023-10-13 | 固安翌光科技有限公司 | Phototherapy device for treating neonatal jaundice |
CN114082109A (en) * | 2021-12-21 | 2022-02-25 | 固安翌光科技有限公司 | Shape-adaptive phototherapy wearing article |
CN114082109B (en) * | 2021-12-21 | 2024-02-06 | 固安翌光科技有限公司 | Conformal phototherapy wearing article |
Also Published As
Publication number | Publication date |
---|---|
CN113730825B (en) | 2024-04-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN113730825B (en) | Phototherapy device | |
CA2666283C (en) | Light delivery system | |
AU750568B2 (en) | Conformal patch for administering light therapy to subcutaneous tumors | |
KR101496370B1 (en) | Light emitting device for use in therapeutic and/or cosmetic treatment | |
US20130178919A1 (en) | Disposable skin care device | |
WO2010064035A1 (en) | Light emitting apparatus | |
US20150190649A1 (en) | Embedded photonic systems and methods for irradiation of medium with same | |
US20210402207A1 (en) | Disposable flexible electronic phototherapy device | |
KR20120062696A (en) | Improved medical apparatus | |
JP2013512063A (en) | Substrate pattern formation | |
CN113730824B (en) | Phototherapy device | |
US20230057208A1 (en) | Devices, systems, and methods for activation of a photoactive agent | |
CN215136019U (en) | Phototherapy device | |
KR20090132416A (en) | Skin injury treatment band using flexible oled and control method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |